chr16-55669586-C-T
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_001172501.3(SLC6A2):c.296C>T(p.Thr99Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0166 in 1,613,980 control chromosomes in the GnomAD database, including 287 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001172501.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A2 | NM_001172501.3 | c.296C>T | p.Thr99Ile | missense_variant | 3/15 | ENST00000568943.6 | NP_001165972.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A2 | ENST00000568943.6 | c.296C>T | p.Thr99Ile | missense_variant | 3/15 | 1 | NM_001172501.3 | ENSP00000457473 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0107 AC: 1621AN: 152182Hom.: 13 Cov.: 32
GnomAD3 exomes AF: 0.00950 AC: 2388AN: 251340Hom.: 25 AF XY: 0.00953 AC XY: 1295AN XY: 135840
GnomAD4 exome AF: 0.0172 AC: 25156AN: 1461680Hom.: 274 Cov.: 32 AF XY: 0.0167 AC XY: 12170AN XY: 727158
GnomAD4 genome AF: 0.0106 AC: 1621AN: 152300Hom.: 13 Cov.: 32 AF XY: 0.0102 AC XY: 758AN XY: 74464
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
SLC6A2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 27, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at